Alerts will be sent to your verified email
Verify Email
VISTAPH
|
Vista Pharma
|
Biofil Chem & Pharma
|
Godavari Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.01 % | 4.39 % | 14.06 % |
|
5yr average Equity Multiplier
|
1.42 | 2.06 | 3.51 |
|
5yr Average Asset Turnover Ratio
|
0.08 | 0.95 | 1.24 |
|
5yr Avg Net Profit Margin
|
-205.63 % | 2.38 % | 3.28 % |
|
Price to Book
|
1.21 | 2.53 | 1.17 |
|
P/E
|
0.0 | 18.89 | 14.29 |
|
5yr Avg Cash Conversion Cycle
|
124.89 Days | 75.63 Days | 107.21 Days |
|
Inventory Days
|
3040.44 Days | 28.27 Days | 47.15 Days |
|
Days Receivable
|
137.33 Days | 389.8 Days | 163.82 Days |
|
Days Payable
|
1845.08 Days | 203.89 Days | 106.32 Days |
|
5yr Average Interest Coverage Ratio
|
-2.88 | 23.53 | 2.61 |
|
5yr Avg ROCE
|
-8.17 % | 6.37 % | 20.07 % |
|
5yr Avg Operating Profit Margin
|
-192.46 % | 3.78 % | 8.03 % |
|
5 yr average Debt to Equity
|
0.26 | 0.03 | 1.34 |
|
5yr CAGR Net Profit
|
19.73 % | -14.7 % | 1.18 % |
|
5yr Average Return on Assets
|
-6.49 % | 2.37 % | 4.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
21.19 % | 46.79 % | 52.61 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.22 % |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | -0.03 % | -4.31 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
|
Vista Pharma
|
Biofil Chem & Pharma
|
Godavari Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|